Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of human disease, including immunology, metabolism, cardiology, and...(
read more)
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) jumped up by 45.70% to close at $2.20 with overall traded volume of 20.61 million shares in the last trading day. The...(
read more)